Guest: Dr. Nick Reed, Assistant Professor in the Department of Epidemiology at Johns Hopkins School of Health.


Topic: The Significance of Johns Hopkins' ACHIEVE Trial


Nick joins Dave on the podcast to talk through one of the recent findings from the Lancet Commission on Dementia, which states that one of the strongest preventative actions to stunt the onset and rate of dementia is to encourage use of hearing aids for hearing loss. 


As the two discuss, while this call to action seems very straightforward, the challenge is that the general medical community needs clinical validation in order to buy into the idea of mass screening for hearing loss (i.e. at one's physician checkup). That's what the ACHIEVE trial is set out to answer - whether or not there's a definitive link between hearing aids providing a some sort of positive effect to the rate of cognitive decline and dementia. 


Nick outlines why this randomized control trial has the potential to serve as one of the most significant driving forces to impacting the broad perception surrounding the comorbidities linked to hearing loss and the preventative measures that can be taken to mitigate said comorbidities.

---

Send in a voice message: https://podcasters.spotify.com/pod/show/futureear/message